White House: COVID-19 vaccines for kids under 5 could be available this month
The White House predicts the youngest Americans could have access to COVID-19 vaccines this month.
pfizer
Pfizer asks FDA to emergency use authorization for COVID-19 vaccine in kids under 5-years-old
Trial results released last week show the vaccine appears safe and has a strong immune response.
Pfizer releases data on COVID-19 vaccine effectiveness in young children
Pfizer says it is ready to submit its vaccine to the FDA for emergency use authorization for children 6 months to 5 years old, releasing preliminary data about effectiveness.
Pfizer says 3 COVID shots protect children under 5
Associated Press (AP)
Pfizer says three small doses of its COVID-19 vaccine protect kids under 5.
Study finds fourth dose of Moderna or Pfizer vaccine provides “substantial” boost in COVID-19 immunity
A fourth dose is already authorized in the U.S. for people 50 and older.
FDA encouraging Americans to get Pfizer or Moderna COVID-19 vaccines over J&J
New data shows COVID-19 hospitalizations and deaths are on track to rise for the first time in months, and the FDA is encouraging Americans to get either the Moderna or Pfizer vaccines over the Johnson & Johnson shot.
Pending approval, Pfizer says it could have COVID-19 shots for kids under 5 by June
Some big news for parents. The COVID-19 vaccine could be available for children under five-years-old by summer.
Study finds third COVID-19 vaccine dose shows “high immune response” in kids ages 5-11
Kids ages 5-11 may soon be eligible for a COVID-19 booster shot. Pfizer and BioNTech plan to submit for emergency use authorization, after the companies say results from a study reveal a third vaccine dose in that age group shows “high immune response.”
Pfizer to seek COVID booster for healthy 5- to 11-year-olds
Pfizer wants to expand its COVID-19 booster shots to healthy 5- to 11-year-olds. Pfizer said Thursday new data shows its kid-sized booster could help healthy elementary-aged children rev up virus-fighting antibodies.
Wednesday meeting provides no clear answers on future booster shot guidance
Health care providers hoping to get new guidance on coronavirus vaccines from the FDA will have to keep waiting. Wednesday’s meeting ended with no solid answers regarding the future of booster shots and regular vaccines.
